Sanofi (NASDAQ:SNY) Announces Quarterly Earnings Results, Misses Expectations By $0.06 EPS

Key Points

• Sanofi reported a quarterly earnings per share (EPS) of $0.90, which missed analysts' expectations by $0.06, while revenue was significantly higher than estimates at $11.34 billion.
• The company experienced a 7.0% decline in revenue compared to the same quarter last year, with the prior year's EPS at $1.73.
• Despite the earnings miss, several analysts maintain an "overweight" or "buy" rating on Sanofi's stock, with a consensus target price of $62.00.

Sanofi (NASDAQ:SNY - Get Free Report) released its quarterly earnings data on Thursday. The company reported $0.90 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.96 by ($0.06), Zacks reports. Sanofi had a return on equity of 18.85% and a net margin of 21.47%. The firm had revenue of $11.34 billion for the quarter, compared to analyst estimates of $9.91 billion. During the same quarter in the previous year, the business posted $1.73 earnings per share. Sanofi's revenue for the quarter was down 7.0% on a year-over-year basis.

Sanofi Trading Up 2.4%

SNY stock traded up $1.11 during mid-day trading on Friday, hitting $46.75. 2,518,877 shares of the company were exchanged, compared to its average volume of 2,122,035. The company has a quick ratio of 0.69, a current ratio of 1.37 and a debt-to-equity ratio of 0.16. The firm has a market capitalization of $114.65 billion, a P/E ratio of 11.24, a PEG ratio of 1.05 and a beta of 0.48. The business has a fifty day simple moving average of $49.10 and a 200-day simple moving average of $52.08. Sanofi has a 12-month low of $44.73 and a 12-month high of $60.12.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of SNY. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Sanofi by 1.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 49,255 shares of the company's stock valued at $2,732,000 after purchasing an additional 752 shares during the period. AQR Capital Management LLC boosted its stake in shares of Sanofi by 107.2% in the first quarter. AQR Capital Management LLC now owns 30,518 shares of the company's stock valued at $1,693,000 after purchasing an additional 15,791 shares during the period. Finally, Brighton Jones LLC boosted its stake in shares of Sanofi by 52.6% in the fourth quarter. Brighton Jones LLC now owns 5,420 shares of the company's stock valued at $261,000 after purchasing an additional 1,869 shares during the period. Hedge funds and other institutional investors own 14.04% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on SNY shares. Barclays restated an "overweight" rating on shares of Sanofi in a research report on Wednesday, July 2nd. Hsbc Global Res upgraded shares of Sanofi to a "strong-buy" rating in a research report on Monday, April 28th. Wall Street Zen upgraded shares of Sanofi from a "hold" rating to a "buy" rating in a research report on Saturday. Morgan Stanley set a $56.00 price objective on shares of Sanofi in a research report on Monday, June 2nd. Finally, Guggenheim restated a "buy" rating on shares of Sanofi in a research report on Tuesday, June 3rd. Two research analysts have rated the stock with a hold rating, four have issued a buy rating and three have assigned a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus target price of $62.00.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.